Table 6.

Discharge practices and postdischarge follow-up care and knowledge related to NAS, sample respondents in California Birth Hospitals in 2018.

Category	%	95% CI		# of hospitals
Seldom or never discharge infants while still on pharmacologic therapy for NAS (n = 57)	81%	68%	89%	46
Postdischarge follow-up provided to the parent, guardian, or caretaker of infants under observation or being treated for NAS related to opioid exposure (n = 63)
Scheduling of pediatrician visits	89%	79%	95%	56
Referral for pediatrician visits	68%	56%	78%	43
Home visit nursing	43%	31%	55%	27
Scheduling of maternal primary care physician visits	37%	26%	49%	23
Referral to a specialized program for NAS or high-risk infants	33%	23%	46%	21
Referral for maternal primary care physician visits	29%	19%	41%	18
Familiar with home visiting services (n = 63)	44%	33%	57%	28

Source: “Hospital Care and Emerging Practices for Treatment of Maternal Opioid Addiction, the Mother-Infant Dyad and Neonatal Abstinence Care: A Survey of California Hospitals” fielded June 2018 to August 2018 by the Urban Institute in collaboration with the California Perinatal Quality Improvement Collaborative and the California Maternal Quality Care Collaborative

n  = sample size. Denominator includes all respondents who selected a response in any part of the question (e.g., in a multi-item response table). A respondent who selected an answer in one line of the table but left another line blank are treated as “no” (instead of “missing”) for the line or lines for which they did not respond

NAS neonatal abstinence syndrome, CI confidence interval